Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 287.00x is 48% above its 4-year average of 194.05x, near the high end of its 4-year range (85.42x–310.85x).
As of the fiscal period ended Sunday, September 30, 2012. 16.72% above its 12-month average of 245.89x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2012 (2012-09-30): 287.00x.
INTEREST COVERAGE RATIO
287.00x
INTEREST COVERAGE RATIO AVG TTM
245.89x
INTEREST COVERAGE RATIO AVG 3Y
201.95x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+16.72%
CURRENT VS 3Y AVG
+42.12%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
+6884.87%
vs the sector median at left
HealthStream, Inc.
Market Cap
$913.56M
Interest Coverage Ratio
287.00x
TTM Avg
245.89x
3Y Avg
201.95x
5Y Avg
N/A
Market Cap
$905.78M
Interest Coverage Ratio
2.21x
TTM Avg
2.21x
3Y Avg
2.21x
5Y Avg
5.08x
Market Cap
$935.68M
Interest Coverage Ratio
-200.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$935.25M
Interest Coverage Ratio
-30.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$882.01M
Interest Coverage Ratio
-278.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$938.73M
Interest Coverage Ratio
-33.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$875.38M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$854.51M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$853.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $913.56M | 287.00x | 245.89x | 201.95x | N/A |
| Bioventus Inc. (BVS)vs › | $905.78M | 2.21x | 2.21x | 2.21x | 5.08x |
| Kura Oncology, Inc. (KURA)vs › | $935.68M | -200.81x | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $935.25M | -30.90x | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $882.01M | -278.88x | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $938.73M | -33.78x | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $875.38M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $854.51M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $853.77M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $971.43M | N/A | N/A | N/A | N/A |
Interest Coverage
287.0x
Debt/Equity
0.04
Current Ratio
1.06
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2012-09-30 | 287.00x |
| 2012-06-30 | 310.85x |
| 2012-03-31 | 195.08x |
| 2011-12-31 | 229.31x |
| 2011-09-30 | 207.23x |
| 2011-03-31 | 270.07x |
| 2010-12-31 | 164.71x |
| 2010-09-30 | 171.89x |
| 2010-06-30 | 232.39x |
| 2010-03-31 | 128.36x |
| 2009-12-31 | 141.07x |
| 2009-09-30 | 85.42x |
| 2009-06-30 | 198.27x |
| 2009-03-31 | 95.09x |
